The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

Abstract

The NLR, an easily obtained inflammatory biomarker, independently predicts CV risk and all-cause mortality, and is reduced by interleukin-1β blockade with canakinumab.